Consumer, metal stocks weigh on Indian shares
Updates at 10:25 a.m. IST
By Bharath Rajeswaran and Hritam Mukherjee
Oct 24 (Reuters) -Indian shares fell on Thursday, weighed down by consumer stocks after major Hindustan Unilever posted a smaller-than-expected second-quarter profit, while aluminium maker Hindalco fell on a weak demand outlook and dragged metal stocks lower.
The NSE Nifty 50 .NSEI fell 0.12% at 24,407.35 points as of 10:25 a.m. IST, while the BSE Sensex .BSESN shed 0.1% to 80,008.
The Nifty 50 has lost 1.7% in the previous three sessions this week and is down about 7% since hitting a record high on Sept. 27, dragged by foreign selling and largely lacklustre earnings.
"Investor mindset has turned gloomy with the tepid earnings and a knee-jerk reaction from foreign investors, which has hurt the market sentiment," said Vinod Nair, head of research at Geojit Financial Services.
Foreign institutional investors were net sellers of Indian shares for the eighteenth straight session on Wednesday, redirecting funds to China on stimulus measures and relatively cheaper valuations.
Hindustan Unilever HLL.NS fell 5.5%, eyeing its worst session in nine months, after the Dove soap maker posted a smaller-than-expected quarterly profit on Wednesday, hurt by a slowdown in urban markets and higher costs.
The FMCG index .NIFTYFMCG fell 2% and was the top sectoral loser by percentage.
Hindalco Industries HALC.NS dropped 5.9% and was the top loser in the metal index .NIFTYMET, which fell 0.3%.
"Hindalco is losing on the day, as fears spill over from rival Constellium's downbeat forecast, where it flagged challenges increasing on macroeconomic front, impacting demand across most end markets," Tushar Chaudhuri, a research analyst with Prabhudas Lilladher said.
Five of the 13 major sectors logged losses. The broader, more domestically focused small .NIFSMCP100 and mid-caps .NIFMDCP100 rose 0.6% and 0.4%, respectively.
Among individual stocks, AU Small Finance Bank AUFI.NS rose 2.25% after posting a higher net profit in the September quarter.
Aster DM Healthcare ATRD.NS jumped 11.2% to a record high after posting a net profit in the September quarter compared to a loss a year ago.
($1 = 84.0730 Indian rupees)
Reporting by Bharath Rajeswaran and Hritam Mukherjee in Bengaluru; Editing by Sumana Nandy and Abinaya Vijayaraghavan
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
